New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: effects of targeted disruption of the type 5 adenylyl cyclase gene.

New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: effects of targeted disruption of the type 5 adenylyl cyclase gene.

Item
http://www.wikidata.org/entity/Q37409127
Disruption of adenylyl cyclase type V does not rescue the phenotype of cardiac-specific overexpression of Galphaq protein-induced cardiomyopathyStructural basis for the high-affinity inhibition of mammalian membranous adenylyl cyclase by 2',3'-o-(N-methylanthraniloyl)-inosine 5'-triphosphate.Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain TransitionAdenylyl cyclase type 5 in cardiac disease, metabolism, and aging.Effect of MANT-nucleotides on L-type calcium currents in murine cardiomyocytes.Role of phosphodiesterase 4 expression in the Epac1 signaling-dependent skeletal muscle hypertrophic action of clenbuterol.Oscillation of cAMP and Ca(2+) in cardiac myocytes: a systems biology approach.North American ginseng (Panax quinquefolius) suppresses β-adrenergic-dependent signalling, hypertrophy, and cardiac dysfunction.Supra-therapeutic doses of roflumilast have no effect on cardiac repolarization in healthy subjects.Role of cyclic AMP sensor Epac1 in masseter muscle hypertrophy and myosin heavy chain transition induced by β2-adrenoceptor stimulation.
P2860

New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: effects of targeted disruption of the type 5 adenylyl cyclase gene.

Item
http://www.wikidata.org/entity/Q37409127
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New aspects for the treatment ...... type 5 adenylyl cyclase gene.
@en
New aspects for the treatment ...... type 5 adenylyl cyclase gene.
@nl
type
label
New aspects for the treatment ...... type 5 adenylyl cyclase gene.
@en
New aspects for the treatment ...... type 5 adenylyl cyclase gene.
@nl
prefLabel
New aspects for the treatment ...... type 5 adenylyl cyclase gene.
@en
New aspects for the treatment ...... type 5 adenylyl cyclase gene.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
New aspects for the treatment ...... type 5 adenylyl cyclase gene.
@en
P2093
P304
P31
P356
P433
P478
P577
P698